Ion Exchange India Reports FY26 Results

Ion Exchange (India) Limited posted consolidated operating income of ₹2,914.80 crore for the fiscal year ended March 31, 2026, marking a 6.5% increase from ₹2,737.10 crore in FY25.

Reader Takeaway: Revenue growth was positive, but margin compression and profit decline are key concerns for investors.

What just happened

Ion Exchange India's financial results for FY26 show a 6.5% year-on-year increase in operating income to ₹2,914.80 crore. Despite the revenue growth, net profit declined by 31.3% to ₹143.20 crore. The company's EBITDA margin compressed to 7.21% in FY26 from 10.74% in FY25.

Why this matters

The significant drop in net profit and margin compression, despite revenue growth, indicates pressure from rising input costs and operational expenses. The company cited facility-specific costs at its Roha facility and logistical disruptions due to the West Asia crisis impacting exports.

The backstory

Ion Exchange has been focusing on expanding its engineering and chemicals segments, alongside securing new projects globally. The company has a history of managing large water treatment and chemical process projects.

What changes now

Ion Exchange has implemented cost-pass-through measures to mitigate current pressures. The company ended FY26 with a strong order book of ₹2,643.30 crore and a bid pipeline of ₹9,509.00 crore, providing revenue visibility.

Risks to watch

Margin pressure from input costs and logistical challenges, particularly those related to geopolitical events in West Asia, remain key risks. The effectiveness of cost-pass-through initiatives will be crucial.

Peer comparison

While direct peer financial comparisons are not provided in the filing, the water treatment and chemicals sector generally faces similar challenges related to raw material costs and global supply chain disruptions.

Context metrics (time-bound)

• Orderbook (as of March 31, 2026): ₹2,643.30 crore
• Bid Pipeline (as of March 31, 2026): ₹9,509.00 crore
• FY26 Operating Income: ₹2,914.80 crore (6.5% YoY growth)
• FY26 Net Profit: ₹143.20 crore (31.3% YoY decline)
• FY26 EBITDA Margin: 7.21% (down from 10.74% in FY25)

What to track next

Investors will be closely watching the company's ability to restore margins in the upcoming quarters through its cost-pass-through initiatives and the stabilization of its Roha facility operations. The execution of its significant order book and bid pipeline will also be key.

Operational Highlights:

• Engineering: Commissioned Raw Water Treatment Plant for IOCL's Panipat refinery. GCC contracts are proceeding.
• Chemicals: Achieved WQA certification and commissioned manufacturing lines at Roha. Faced input cost volatility and export logistics issues.
• Strategic Collaboration: Entered a technology transfer partnership with MANN + HUMMEL for membrane solutions.